Fulbright-Fogarty Public Health Fellowship Award NEW
Accepted Degree Levels
Grant PeriodSummer Start
Grant Length9 Months
Specialized Grant Types
- Science/Public Health
The Fulbright-Fogarty fellowship in Uganda offers U.S. post-graduate students in the health sciences practical experience designing and conducting clinical research in Uganda.
Affiliations: Infectious Diseases Institute, College of Health Science, Makerere University, Kampala, Uganda https://idi.mak.ac.ug/
Fellows would be expected to work with U.S. and Ugandan mentor groups to develop an independent research project that could be integrated into one of the following projects or in a new area of interest:
· Risk factors for cardiovascular diseases in people living with HIV and the development of new devices/screening tools for use in low-resource settings
· Piloting and validating scalable tools for screening of geriatric syndromes in people with HIV focusing on self collected patients reported outcomes
· Validation of tools for the screening of dementia in people aging with HIV
· Acute febrile illness epidemiology and new diagnostic tools
· Pandemic preparedness
· SARS-CoV-2 international biorepository and diagnostic test performance
· Community pharmacies for assessing sexually transmitted infections using point-of-care diagnostics study (COPHAS)
· Current ongoing projects that are accepting scholars and fellows include: the long term antiretroviral treatment cohort (patients on ART for >15 years) and the cohort of patients aging with HIV (>60 years old); Sexually transmitted disease epidemiology in community pharmacies, COVID-19 rapid acceleration of diagnostics in international settings
U.S. Partner: UJMT Launching Future Leaders in Global Health (LAUNCH) https://globalhealth.unc.edu/education/fellowships-and-training-programs/ujmt-fogarty-global-health-fellowship/
Barbara Castelnuovo firstname.lastname@example.org
Yuka Manabe email@example.com
Site name: Mbarara University of Science and Technology (MUST)
Mbarara University of Science and Technology also known as MUST lies on the banks of the scenic meandering Rwizi River a tributary of Lake Victoria in Mbarara Municipality along the Kabale highway, 286 kilometers, southwest of Kampala, the capital city of Uganda. Learning and living are intimately intertwined at MUST. Extra-Curricular activities, professional student associations and clubs, performances, forums and sports and games beckon students as well as the communities around the University. The Students’ Guild mission is to improve the quality of student’s life at the university, both academically and socially by addressing student needs and concerns, providing financial structure for student clubs and organizations and representing the student body in a professional manner. MUST provides access for students and staff to LAN and internet services through cabled internet services in staff offices and student computer rooms and labs and through the university’s wireless network cloud for both staff and students using the university’s active directory usernames and passwords.
MUST shares a campus with Mbarara Regional Referral Hospital (MRRH) in Mbarara, Uganda. MRRH is 300-bed hospital sharing the MUST campus. It is the sole teaching and referral hospital for southwest Uganda, a region of 36,870 square kilometers and a population of over 5 million, representing 18% of Ugandans. The Ministry of Health provides MRRH with regular medical supplies, free antiretrovirals and medications, and diagnostic equipment. The Immune Suppression Syndrome (ISS) Clinic, a PEPFAR-funded clinical site, serves as the hospital’s HIV outpatient clinic, and is run primarily by the Department of Internal Medicine at MUST. ISS occupies 8,000 square feet, and there are over 16,000 registered patients, with 180 new patients registered each month on average. All antiretroviral therapy is provided free of charge, as is CD4 cell count and viral load testing every six months. The ISS Clinic is an IeDEA networks site with a high-quality clinical database.
The HIV clinic at MUST and MRRH in Mbarara, Uganda cares for 12,000 active patients living with HIV, with approximately 1,000 patients initiating ART each year.
Site Website: http://www.must.ac.ug/about-must
Francis Bajunirwe, Senior Lecturer, Department of Community Health
Email : firstname.lastname@example.org
Stephen Asiimwe, Program Director, MUST-Massachusetts General Hospital (MGH) Global Health Collaborative
Francis Bajunirwe, Senior Lecturer, Department of Community Health
Joseph Ngonzi, Senior Lecturer (Obstetrics/Gynecology) and Dean-Elect, MUST
Samuel Maling, Associate Professor of Psychiatry, Faculty of Medicine, MUST
Conrad Muzoora, Physician and Senior Lecturer, Internal Medicine,
Samson Okello, Lecturer, Department of Internal Medicine, MUST
Examples of ongoing projects:
D43TW011632-01 9/1/2020-5/31/2025 Multi-morbidity in Uganda Research Capacity Initiative (MURCI)
NIH/NIMH K24MH114732 07/1/2017–06/30/2022 Optimizing mHealth for adherence monitoring and intervention
NIH 1R01HL141053 08/01/2018– 07/31/2022 Epidemiology of Coronary Artery Disease (CAD) among people with HIV in rural sub-Saharan Africa.
R01NS086312-08 09/01/2013-04/30/2024 NIH NINDS Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
NIH/NIAID U01 AI150508-01A1 09/18/2020-06/30/2025 A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa.
EDCTP TRIA2015-1092 05/01/2018 - 12/31/2021 High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: A Phase 3 Randomised Controlled Non-Inferiority Trial
MUST receives significant funding various organizations from across the world, including The European Union, the Wellcome Trust, and VLIR-OUS Belgium all aimed at capacity building. These funds provide extensive resources and facilities which will be available for fellows. MUST has an extensive infrastructure in place in the form of clinical, lab, and grant support. These facilities are available for all fellows and trainees and have contributed to the success of prior researchers in the form of numerous NIH and non-NIH grants.
MUST has numerous collaborations with institutions from across the world – the primary ones being Massachusetts General Hospital (MGH), the University of California San Francisco (UCSF), and the University of Virginia to name a few. There are over 30 active research studies currently ongoing. MGH and MUST have a well-established collaboration dating back to 2003 with researchers from various medical fields visiting and living in Mbarara. Owing to multi-year success, the MUST-MGH partnership has developed an extensive research infrastructure in Mbarara. The Collaboration owns vehicles for research transport and in conjunction with MGH leases a fully furnished guest house and supports several full-time field-staff based in Mbarara. MUST also has a highly functional Contracts and Grants Office, which received over $7 million in extramural funding in 2018.
The main U.S. partner for this site is Harvard University and Massachusetts General Hospital (MGH). Researchers from Massachusetts General Hospital (MGH) has collaborated with MUST for over 10 years. For nearly two decades, dozens of MGH researchers and staff have worked closely with MUST with this collaboration resulting in numerous NIH grants for US-based and Ugandan-based colleagues.
- Prof. Wafaie Fawzi: email@example.com Professor of Global Health, Nutrition, and Epidemiology; Department of Global Health and Population, Harvard Chan School of Public Health
- Jordan Balletto: firstname.lastname@example.org
Affiliation name: Makerere College of Health Sciences
Summary of the site/ongoing research projects/topics of interest:
The Makerere University College of Health Sciences (MaKCHS) is one of the leading medical universities in Sub-Saharan Africa. Its mission is to improve the health of people of Uganda through innovative teaching and research and provision of services responsive to societal needs.
Major research areas include:
· Lung health,
· Non-communicable chronic diseases,
· Vector-borne diseases
Uganda TB Implementation Research Consortium (U-TIRC)
MakCHS hosts U-TIRC, which is a collaboration involving Makerere University, the Uganda Ministry of Health, the Uganda National TB and Leprosy Programme, and international collaborators from the University of California San Francisco, Yale University, Johns Hopkins University, and the London School of Hygiene and Tropical Medicine. With engagement with key health system stakeholders in Uganda, the Consortium focuses on improving tuberculosis diagnostic evaluation, case finding, and linkage to care by undertaking high quality clinical, epidemiological and implementation science research. U-TIRC is focused on identifying barriers to TB evaluation, developing novel interventions to address the barriers, and evaluating the impact and effectiveness of implementing these interventions in different community and clinic settings in Uganda. The resources that U-TIRC provides is a major strength of the TB implementation research environment in Uganda and at Makerere.
Infectious Diseases Institute (IDI)
IDI is a Ugandan not-for-profit organization whose mission is to strengthen health systems in Africa, with a strong emphasis on infectious diseases, through research and capacity development. Established within Makerere University in 2002, the Institute currently provides care and treatment services to over 100,000 people living with HIV in urban and rural settings in Uganda (about 10% of all PLHIV in the country). IDI is also a national referral center for complicated cases of HIV and it has a diverse research program comprising over 40 projects, prioritizing long- term outreach programs to build capacity across Uganda.
Makerere Lung Institute
The MLI is a research institute that was established in 2015 to respond to the epidemic of lung diseases in Uganda and other similar resource-limited settings. With the support of MaKCHS, the Makerere Lung Institute seeks to conduct lung health research that integrates disease prevention, clinical care and training. MLI hosts a monthly Day of Lung Science, which provides a forum for presentation of and feedback on scientific research by local investigators active in clinical and implementation research in TB in Uganda.
The Integrated Biorepository of H3Africa Uganda (IBRH3AU) is a biorepository located at MaKCHS with state-of-the-art facilities with the capacity to store over 400,000 samples. Its mission is to provide researchers with relevant genomic analyses to test new diagnostics, personalize treatment options and develop new treatment methods. The facilities also provide specimen processing and biobanking services of high quality and low cost, and are accessible on a recharge basis to faculty, staff, and overseas scientists collaborating with MaKCHS. Services offered include processing of peripheral blood mononuclear cells, storage of serum, plasma, and whole blood, as well as culture isolates in an affiliated BSL3 laboratory.
US Partner/Consortia Name: Global Health Equity Scholars, Yale University
Site Contact/PI: J. Lucian Davis, MD, MAS: email@example.com
Affiliation: Infectious Diseases Institute (IDI)
The Infectious Diseases Institute (IDI) is a Ugandan non-government organization owned by Makerere University with the mission: “To strengthen health systems in Africa through research and capacity building”. IDI provides comprehensive services for over 250,000 people with HIV and other infectious diseases in Uganda. It is unique in resource-limited settings as a one-stop site for mentees providing access to patients, samples, CAP certified laboratory, translational laboratory, statistic support, a variety training and short courses.
The research program hosts more than 100 research projects. The program has several collaborations with institutions based in the US and Europe; IDI collaborates with UCSF on a U54 project on Kaposi Sarcoma (PI: Martin J). Key areas of research are HIV and HIV related co-infection and cancers (clinical and lab based). Fellows can leverage existing programs, particularly the HIV clinic located at the Mulago site which hosts specialized services and grants on sexual and reproductive health, mental health, non-communicable diseases, treatment failure, Kaposi sarcoma diagnostic, TB co-infections and two ongoing cohorts (along-term outcomes cohort and a geriatric cohort).
While working within their proposed projects, all scholars and research fellows at IDI are offered training through orientation, journal clubs, research fellows peer support club, a short course on scientific writing, monthly soft skills training (e.g. how to formulate a research questions, how to present, PowerPoint skills etc.), and a weekly research forum.
The research capacity building unit within the research department provides infrastructural support, management of finances, administrative and regulatory support and oversight, internal monitoring, and the IDI scholars community for peer support and exchange.
For trainees with lab-based projects, the research translational lab has a microbiology section (BACTEC machine, incubators, biosafety cabinets, fluorescent microscopes (iLED Primostar Zeiss & Zeiss mercury vapor lamp), a molecular section (RT-PCR machine (AB 7500), convectional PCR, bio-fire machines, Gene Xpert) , an immunology section (FACS Canto II flow cytometer, MiniMACs cell separator, Luminex MAGPIX, ELISA washer and plate reader), and a PK section (2 HPLC machines and a mass spectrophotometer).
U.S. Partner: GloCal Health Fellowship Consortium (GloCal)
Site Contact: Dr. Barbara Castelnuovo
Affiliation: Infectious Diseases Research Collaboration (IDRC)
The Infectious Diseases Research Collaboration (IDRC) is a not-for-profit organization, established in 2008 by Ugandan health scientists from Makerere University and the Ministry of Health (MoH) to conduct research in infectious diseases. IDRC has active memoranda of understanding with Makerere University, MoH and UCSF to conduct research in infectious diseases, including malaria, HIV, and tuberculosis. The mission of IDRC is to conduct high-quality research in infectious and other diseases of public health importance through collaboration and partnerships. Specific objectives including: I) To build capacity through training, technology advancement and improvement of local health service infrastructure; II) To conduct research in infectious diseases such as malaria, HIV/AIDS, tuberculosis and other diseases of public importance; III) To disseminate results of research and promote an evidence-based approach to policy making by linking researchers and policy makers; IV) To support the efforts of the Uganda Ministry of Health, Mulago Hospital and other health institutions in Uganda in prevention, care and treatment of infectious diseases.
The collaboration includes over thirty faculty at MU and UCSF, with a budget of $10 million and over 50 publications annually. Some of the important projects that could be leveraged for training future GloCal fellows include:
- A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa.
- Program for Resistance, Immunology, Surveillance, and Modeling of Malaria in Uganda.
- Optimal chemo-preventive regimens to prevent malaria and improve birth outcomes in Uganda.
- Integrated HIV/HTN, (Leveraging the HIV platform for hypertension control in Uganda).
- Programs studying immune responses to malaria infection, antimalarial drug resistance and treatment efficacy, antiretroviral therapy initiation, HIV-associated pneumonia, and TB.
FIC, GloCal, K43 and G11 funded programs have trained and built capacity of over 80 Ugandan junior scientists and administrators. IDRC has facilities and resources with over 20 administrators to support trainees. The facilities include office space at its headquarters and research sites in Tororo, Mbale and Mbarara; a reference malaria laboratory; a research infrastructure for clinical, translational, and molecular research; and modern data management centers in Kampala and Tororo.
U.S. Partner: GloCal Health Fellowship Consortium (GloCal)
Site Contact: Dr. Moses Kamya
Grants will begin between August 2023 and March 2024, subject to the approval of the U.S. Embassy in Kampala.
Grantees will be required to participate in a Virtual Pre-Departure Orientation (VPDO) in June/July 2023 as a condition of their grants.
In addition, grantees will be required to participate in a Pre-Departure Orientation with NIH in July.
Candidates must be enrolled in an MD, PhD, DDS or comparable degree from an accredited domestic or foreign institution. Eligible doctoral degrees include, but are not limited to: DMD, DC, DO, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, DPT, PharmD, ND, DSW, PsyD, JD and Doctorate of Philosophy in Nursing.
Must be enrolled in accredited doctoral level program (MD, PhD or equivalent) in public health, government, business, design, engineering, education, medicine, nutrition, law, pharmacy, dentistry, veterinary medicine, and nursing.
Postdoctoral applicants may also apply.
Health-professional students who wish to interrupt their studies for a year or more to engage in full-time research training before completing their formal training programs are also eligible.
Accepted Degree Levels
Special Application Instructions
Applicants must select "Fulbright-Fogarty" in the Award Type field of the application.
All Fulbright-Fogarty applicants should select “Public Health” as the Field of Study in the Fulbright application.
Foreign Language Proficiency
Fulbright Proposal Types
Letter required for independent study or research at deadline
Applicants are required to obtain a letter of support from the site contact.
When emailing project contacts, please include both contacts and attach a current CV and a concise statement (less than 500 words) about your interest in the program (especially your primary research interest).